Unknown

Dataset Information

0

Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction.

ABSTRACT:

SUBMITTER: Lin C 

PROVIDER: S-EPMC8129692 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction.

Lin ChangDong C   Li Yue Y   Zhang YueBin Y   Liu ZhaoYuan Z   Mu Xia X   Gu Chenjian C   Liu Jing J   Li Yutang Y   Li GuoHui G   Chen JianFeng J  

Signal transduction and targeted therapy 20210518 1

Similar Datasets

Unknown Correction To: Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction.
| S-EPMC8190569 | biostudies-literature
Unknown Ceftazidime exhibits a broad inhibition to the infection of SARS-CoV-2 prototype and Omicron variant in vitro by blocking spike protein-ACE2 interaction.
| S-EPMC10028314 | biostudies-literature
Unknown Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay.
| S-EPMC9743696 | biostudies-literature
Unknown Identification and characterization of a monoclonal antibody blocking the SARS-CoV-2 spike protein-ACE2 interaction.
| S-EPMC8100359 | biostudies-literature
Unknown A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2.
| S-EPMC7832953 | biostudies-literature
Unknown Anti-Fungal Drug Anidulafungin Inhibits SARS-CoV-2 Spike-Induced Syncytia Formation by Targeting ACE2-Spike Protein Interaction.
| S-EPMC8990323 | biostudies-literature
Unknown Peimine inhibits variants of SARS-CoV-2 cell entry via blocking the interaction between viral spike protein and ACE2.
| S-EPMC9353385 | biostudies-literature
Unknown Mulberry Component Kuwanon C Exerts Potent Therapeutic Efficacy In Vitro against COVID-19 by Blocking the SARS-CoV-2 Spike S1 RBD:ACE2 Receptor Interaction.
| S-EPMC9604257 | biostudies-literature
Unknown Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.
| S-EPMC9011661 | biostudies-literature
Unknown Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production.
| S-EPMC9880737 | biostudies-literature